Drug profile · INN
haloperidol lactate
HALOPERIDOL
haloperidol lactate (HALOPERIDOL) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Drug details — haloperidol lactate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.89
Quick answer
haloperidol lactate (HALOPERIDOL) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Serotonin 2a (5-HT2a) receptor antagonist
Primary target: D2-like dopamine receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is haloperidol lactate?
haloperidol lactate (HALOPERIDOL) is a serotonin 2a (5-ht2a) receptor antagonist. Associated with Teva Pharma GmbH. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for haloperidol lactate?
HALOPERIDOL is a marketed brand name for haloperidol lactate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of haloperidol lactate?
haloperidol lactate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.